Drª. Shilan Aslani
Neurocientista e Diretora da Clínica
Drª. Shilan Aslani
Neurocientista e Diretora da Clínica
sobre mim
I am the founder of the NeuroImprove clinic and Academy, however, my story doesn’t start like this. With the dream of finding a cure for genetic diseases and of course winning the Nobel Prize, I started my educational path in the field of genetics.
During my master’s, I discovered my interest in the brain and neurological diseases. So, by the time I started my Ph.D. I totally forgot about genetics and set my project goals to study the effect of chronic stress and food intake on the brain’s morphology and function. Interestingly, the more time passed throughout my research, the more I found myself turning away from my initial proposal, and going towards studying emotions and behaviors.
I learned and discovered how environmental factors can directly affect our brains’ morphology and functionality and more importantly how these brain alterations can influence our emotions, behaviors, and even personality. By the end of my degree, I was so fascinated with my findings that I decided to skip the Nobel Prize, gather all my knowledge, connect all of these factors together, and find a more complete intervention for mental and neurological diseases, and this was how NeuroImprove clinic was born.
I have to admit, it was a hard path until I discovered and mastered the neurofeedback technique. I believe that Neurofeedback is in its early stages and thanks to the rapid evolution of technology can still grow a lot. Therefore, there is a high demand for Neurofeedback investigators, instructors, and clinicians. That is why besides the clinical work, I also teach and do mentoring to help passionate professionals like me learn and work with this awesome technique.
Academic Education
- Ph.D. Degree – Neuroscience field, Life and Health Sciences Research Institute (ICVS), Minho University, Braga, Portugal
- Thesis Title: Dissecting The crosstalk between Stress, Depression, and Obesity.
- Master Degree – Molecular Medicine field, Imperial College London, London, United Kingdom
- Thesis Title: Study of Transduction Patterns of Pseudotyped Lentiviral Vectors in Primary Motor Neuron Cultures and Neuro-Muscular Co-cultures.
- Bachelor Degree – Cellular and Molecular Biology, Department of Medicine, Azad University, Tehran, Iran
Professional History
- Founder and CEO: NeuroImprove Clinic, Porto, Portugal (2015 – Current)
- Research assistant: Hammersmith Hospital Campus, Imperial College London, London, UK ( 2010 – 2011)
- Research assistant: Diabetes and bio-nanotechnology units in Endocrinology & Metabolism Research Institute (EMRI), Tehran University of Medical Sciences, Tehran, Iran (May 2008 – Aug 2010)
- Medical assistance and technical Manager: White Complex laser clinic (beauty and health center), Tehran, Iran (2002 – 2003)
Other Certifications
- The pedagogical training course, Joviform, Porto, Portugal (2020)
- BCIA neurofeedback certification, BFE (Biofeedback Federation of Europe), Portugal (2017)
- Neurofeedback- 36 BCIA Didactic Hours, New Mind Academy, E-learning, United State of America (2016)
- The introductory course in Neurofeedback, Euibion, Germany (2015)
- Laboratory animal science, ICVS, Minho University, Portugal (2013)
- Fundamentals in neuroscience, ICVS, Minho University, Portugal (2013)
- Biostatistics in Health Sciences, ICVS, Minho University, Portugal (2012)
- M.J.Castelhano-Carlos, S. Aslani, N. Sousa (2020) The Impact of Physical Enrichment in the Structure of the Medial Prefrontal Cortex and Nucleus Accumbens of the Adult Male Rat Brain. Neuroscience. In press (https://doi.org/10.1016/j.neuroscience.2020.01.040)
- M. Morais, J. Pereira, S. Aslani, et al, Joao M Besa (2016) The impact of antipsychotic drugs on behaviour: new perspectives from the methylazoxymethanol rodent model of schizophrenia. European Neuropsychopharmacology 26(2): S450-S451
- S. Aslani, N. Vieira, F. Marques, P.S. Costa, N. Sousa, J.A. Palha. (2015) The effect of obesity-inducing high fat diet on rat’s mood and feeding behavior and response to stress. Translational Psychiatry. 5 (684), DOI:10.1038/tp.2015.178
- S. Aslani, M.R. Harb, P.S. Costa, O.F.X. Almeida, N. Sousa, J.A. Palha. (2013) Day and night: The diurnal phase influences the response to chronic mild stress. Frontiers in Behavioral Neuroscience. 8 (82): 1-8, DOI: 10.3389/fnbeh.2014.00082
- K. Mirzaei, A. Hossein-nezhad, S. Aslani, S. Emamgholipour, M. Karimi, S.A. Keshavarz. (2012). Energy Expenditure Regulation via Macrophage Migration Inhibitory Factor (MIF) in Obesity and In Vitro Anti-MIF Effect of Alpinia Officinarum Hance Extraction. Endocrine practice. 18(1): 30-48, PMID: 21803717
- S. Aslani, A. Hossein-nezhad, Z. Maghbooli, K. Mirzae, F. Karimi. (2011) Genetic variation in Macrophage migration inhibitory factor associated with Gestational Diabetes Mellitus and metabolic syndrome. Horm Metab Res. 43(8): 557- 561, PMID: 21512965
- S. Aslani, A. Hossein-nezhad, K. Mirzae, Z. Maghbooli, A.N. Afshar, F. Karimi. (2011). VDR FokI polymorphism and its potential role in the pathogenesis of Gestational Diabetes Mellitus and its complications. Gynecological Endocrinology, 27(12):1055-60, PMID: 21663527
- S. Aslani, A. Hossein-nezhad, K. Mirzae, Z. Maghbooli, S.N. Asgarabad, F. Karimi. (2011) Tandem repeats of the CATT element of macrophage migration inhibitory factor gene may predict GDM severity. European Journal of Inflammation, 9(2): 185-191
- A. Hossein-nezhad, K. Mirzaei, S. Aslani, A. Tootee, F. Karimi. (2011) MIF expression in induced peripheral blood mononuclear cells by vitamin D3 and its potential correlation with resting metabolic rate in obesity. European Journal of Inflammation. 9(2): 125-134
I am the founder of the NeuroImprove clinic and Academy, however, my story doesn’t start like this. With the dream of finding a cure for genetic diseases and of course winning the Nobel Prize, I started my educational path in the field of genetics.
During my master’s, I discovered my interest in the brain and neurological diseases. So, by the time I started my Ph.D. I totally forgot about genetics and set my project goals to study the effect of chronic stress and food intake on the brain’s morphology and function. Interestingly, the more time passed throughout my research, the more I found myself turning away from my initial proposal, and going towards studying emotions and behaviors.
I learned and discovered how environmental factors can directly affect our brains’ morphology and functionality and more importantly how these brain alterations can influence our emotions, behaviors, and even personality. By the end of my degree, I was so fascinated with my findings that I decided to skip the Nobel Prize, gather all my knowledge, connect all of these factors together, and find a more complete intervention for mental and neurological diseases, and this was how NeuroImprove clinic was born.
I have to admit, it was a hard path until I discovered and mastered the neurofeedback technique. I believe that Neurofeedback is in its early stages and thanks to the rapid evolution of technology can still grow a lot. Therefore, there is a high demand for Neurofeedback investigators, instructors, and clinicians. That is why besides the clinical work, I also teach and do mentoring to help passionate professionals like me learn and work with this awesome technique.
Academic Education
- Ph.D. Degree – Neuroscience field, Life and Health Sciences Research Institute (ICVS), Minho University, Braga, Portugal
- Thesis Title: Dissecting The crosstalk between Stress, Depression, and Obesity.
- Master Degree – Molecular Medicine field, Imperial College London, London, United Kingdom
- Thesis Title: Study of Transduction Patterns of Pseudotyped Lentiviral Vectors in Primary Motor Neuron Cultures and Neuro-Muscular Co-cultures.
- Bachelor Degree – Cellular and Molecular Biology, Department of Medicine, Azad University, Tehran, Iran
Professional History
- Founder and CEO: NeuroImprove Clinic, Porto, Portugal (2015 – Current)
- Research assistant: Hammersmith Hospital Campus, Imperial College London, London, UK ( 2010 – 2011)
- Research assistant: Diabetes and bio-nanotechnology units in Endocrinology & Metabolism Research Institute (EMRI), Tehran University of Medical Sciences, Tehran, Iran (May 2008 – Aug 2010)
- Medical assistance and technical Manager: White Complex laser clinic (beauty and health center), Tehran, Iran (2002 – 2003)
Other Certifications
- The pedagogical training course, Joviform, Porto, Portugal (2020)
- BCIA neurofeedback certification, BFE (Biofeedback Federation of Europe), Portugal (2017)
- Neurofeedback- 36 BCIA Didactic Hours, New Mind Academy, E-learning, United State of America (2016)
- The introductory course in Neurofeedback, Euibion, Germany (2015)
- Laboratory animal science, ICVS, Minho University, Portugal (2013)
- Fundamentals in neuroscience, ICVS, Minho University, Portugal (2013)
- Biostatistics in Health Sciences, ICVS, Minho University, Portugal (2012)
- M.J.Castelhano-Carlos, S. Aslani, N. Sousa (2020) The Impact of Physical Enrichment in the Structure of the Medial Prefrontal Cortex and Nucleus Accumbens of the Adult Male Rat Brain. Neuroscience. In press (https://doi.org/10.1016/j.neuroscience.2020.01.040)
- M. Morais, J. Pereira, S. Aslani, et al, Joao M Besa (2016) The impact of antipsychotic drugs on behaviour: new perspectives from the methylazoxymethanol rodent model of schizophrenia. European Neuropsychopharmacology 26(2): S450-S451
- S. Aslani, N. Vieira, F. Marques, P.S. Costa, N. Sousa, J.A. Palha. (2015) The effect of obesity-inducing high fat diet on rat’s mood and feeding behavior and response to stress. Translational Psychiatry. 5 (684), DOI:10.1038/tp.2015.178
- S. Aslani, M.R. Harb, P.S. Costa, O.F.X. Almeida, N. Sousa, J.A. Palha. (2013) Day and night: The diurnal phase influences the response to chronic mild stress. Frontiers in Behavioral Neuroscience. 8 (82): 1-8, DOI: 10.3389/fnbeh.2014.00082
- K. Mirzaei, A. Hossein-nezhad, S. Aslani, S. Emamgholipour, M. Karimi, S.A. Keshavarz. (2012). Energy Expenditure Regulation via Macrophage Migration Inhibitory Factor (MIF) in Obesity and In Vitro Anti-MIF Effect of Alpinia Officinarum Hance Extraction. Endocrine practice. 18(1): 30-48, PMID: 21803717
- S. Aslani, A. Hossein-nezhad, Z. Maghbooli, K. Mirzae, F. Karimi. (2011) Genetic variation in Macrophage migration inhibitory factor associated with Gestational Diabetes Mellitus and metabolic syndrome. Horm Metab Res. 43(8): 557- 561, PMID: 21512965
- S. Aslani, A. Hossein-nezhad, K. Mirzae, Z. Maghbooli, A.N. Afshar, F. Karimi. (2011). VDR FokI polymorphism and its potential role in the pathogenesis of Gestational Diabetes Mellitus and its complications. Gynecological Endocrinology, 27(12):1055-60, PMID: 21663527
- S. Aslani, A. Hossein-nezhad, K. Mirzae, Z. Maghbooli, S.N. Asgarabad, F. Karimi. (2011) Tandem repeats of the CATT element of macrophage migration inhibitory factor gene may predict GDM severity. European Journal of Inflammation, 9(2): 185-191
- A. Hossein-nezhad, K. Mirzaei, S. Aslani, A. Tootee, F. Karimi. (2011) MIF expression in induced peripheral blood mononuclear cells by vitamin D3 and its potential correlation with resting metabolic rate in obesity. European Journal of Inflammation. 9(2): 125-134
Os Meus Cursos
